Serum Institute of India will invest $68.24 million in the UK’s Oxford Biomedica, one of the COVID-19 vaccine manufacturers for drug major AstraZeneca. These funds will be used to develop the fallow area at its Oxbox plant into a manufacturing space which is expected to come online in mid-2023.
Read the original article here: https://www.livemint.com/companies/news/serum-institute-of-india-to-invest-68-million-in-uk-s-oxford-biomedica/amp-11632295347115.html